- Condition: Alzheimer's Disease
Interventions: Drug: LY2886721; Drug: Placebo
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Condition: Alzheimer's Disease
Interventions: Drug: BMS-241027; Drug: BMS-241027; Drug: BMS-241027; Drug: Placebo matching BMS-241027
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb
Recruiting - verified April 2012 - Condition: Alzheimer's Disease
Interventions: Drug: MK-8931; Drug: Placebo
Sponsors: Schering-Plough; Schering-Plough
Recruiting - verified May 2012 - Condition: Alzheimer's Disease
Interventions: Drug: Active Comparator: A; Drug: Placebo Comparator B; Drug: Active Comparator B; Drug: Placebo Comparator A
Sponsors: Eisai Inc.; Eisai Inc.
Recruiting - verified January 2012 - Condition: Alzheimer's Disease
Intervention: Other: 18F-PIB
Sponsors: University of Utah; University of Utah
Recruiting - verified September 2011 - Condition: Alzheimer's Disease
Intervention: Drug: Solanezumab
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Condition: Alzheimer's Disease
Interventions: Genetic: CERE-110: Adeno-Associated Virus Delivery of NGF; Procedure: Placebo Surgery
Sponsors: Ceregene; Ceregene; Alzheimer's Disease Cooperative Study (ADCS)
Recruiting - verified May 2012 - Condition: Dementia
Intervention: Procedure: FDG-PET brain scan
Sponsors: University of California, Los Angeles; University of California, Los Angeles; Centers for Medicare and Medicaid Services
Recruiting - verified April 2012
 |
Join Clinical Trials in Utah for Alzheimers Disease |
